RNS Number : 9232D
Tristel PLC
02 November 2020
Tristel plc
("Tristel" or the "Company")
Q&A update following preliminary results
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, hosted a Preliminary Results Presentation delivered by Paul Swinney, CEO and Liz Dixon, FD on 19 October 2020, which was made available online at: www.tristelresults.com. Facilities were put in place for Shareholders to submit questions to the Company.
The Q&A have now been made available for all Shareholders to view: https://tristelresults.com/wp-content/uploads/2020/10/Tristel-Final-results-QA-FINAL.pdf
For further information please contact:
Tristel plc
|
Tel: 01638 721 500
|
|
Paul Swinney, Chief Executive Officer
|
|
|
Liz Dixon, Finance Director
|
|
|
|
|
|
Walbrook PR Ltd
|
Tel: 020 7933 8780 or [email protected]
|
|
Paul McManus
|
Mob: 07980 541 893
|
|
Lianne Cawthorne
|
Mob: 07584 391 303
|
|
|
|
|
finnCap
|
Tel: 020 7220 0500
|
|
Geoff Nash/ Giles Rolls (Corporate Finance)
|
|
|
Alice Lane (ECM)
|
|
|
|
|
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
NRAUUVKRRRUARRA